Switch to:
Pfizer Inc (NYSE:PFE)
Research and Development
$8,655 Mil (TTM As of Mar. 2015)

This is the expense the company spent on research and development. Pfizer Inc's research and development for the three months ended in Mar. 2015 was $1,885 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2015 was $8,655 Mil.


Definition

This is the expense the company spent on research and development.

Pfizer Inc Research & Development for the trailing twelve months (TTM) ended in Mar. 2015 was 1759 (Jun. 2014 ) + 1802 (Sep. 2014 ) + 3209 (Dec. 2014 ) + 1885 (Mar. 2015 ) = $8,655 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Pfizer Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Research & Development 7,2567,5998,0898,5787,9139,4139,1127,8706,6788,393

Pfizer Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
Research & Development 2,1361,8001,5301,6271,8111,6231,7591,8023,2091,885
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK